Sean Murphy

Sean Murphy

DirectoratTriSalus Life Sciences· In proxies 2022–2025

Pay in FY2024+66% from the year before · TriSalus Life Sciences stock -40.7% the same year

Sean Murphy was paid $2.3M in FY2024 (Dec), up 66%. TriSalus Life Sciences stock fell 40.7% that year.

Pay$100 in the stock at the end of FY21 → $51
Pay is from the Summary Compensation Table of each TriSalus Life Sciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. TriSalus Life SciencesPublic company · 4 yr
    • Director2022 – Present · 4 yrStock in role -60%
  2. PrenosisPublic company
    • Director? – PresentNo stock prices for these years
  3. XenexPublic company
    • Director? – PresentNo stock prices for these years
  4. Xenex Disinfection Services, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Poseida TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  6. Radius HealthPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?